12A - The Michigan Daily - Thursday, February 14, 2002 0 Blue trying to end road woes in Iowa Netters will be tested by SEC By Chaues Paradis Daily Sports Writer With just four games left and practi- cally no shot of reaching the NCAA Tournament, some might say the sea- son is over for the Michigan women's basketball team. But coach Sue Gue- vara is not one of those naysayers, and she will not let her players feel that way either. As the situation stands, Michigan has room to get better, and it is the drive for self improvement that Guevara hopes to grab hold of tonight. One area the Wolverines can improve in is their play away from Crisler Arena. While Michigan owns a 4-1 conference record at home, the Wolverines have not been able to win a Big Ten road game on the road in seven attempts this season. If Michigan wants to snap this road skid, it will need all of its players to play well together, a feat the Wolverines have not been able to accomplish all season. "We've had a player come up every game with big numbers;' Guevara said. "It will be really nice when (LeeAnn) Bies, (Jennifer) Smith, (Stephanie) Gandy and (Alayne) Ingram all can come in on the same page and put some numbers up." Last time out it was Gandy who led the Wolverines offensively, posting a career-high 29 points against Ohio State on Sunday. "Gandy did a very nice job of attack- ing, being very aggressive on both ends of the floor," Guevara said. Gandy has also been a defensive stopper, something the Wolverines may need just as much as her points. Michigan did an excellent job of defending the perimeter last time it played the Hawkeyes. A tenacious defense by the Wolverines slowed down Iowa's sharp shooter Lindsey Meder, who connected on just 5-of-12 from behind the arc. "That's what I thought really helped us the last game against Iowa," Guevara said. "We did a nice job of containing their perimeter players, and we're going to have to have that same type of effort if not a better effort (tonight)." In the second half of the Ohio State game this past Sunday, Michigan CARVER-HAWKEYE ARENA Who: Michigan (4-8 Big Ten, 14-9 overall) at Iowa (8-5, 15-8) When:8 p.m. 1 Latest: Iowa's sharshooting guard Lindsey Meder went 5-of-12 from behind the arc in the team's first meeting this season. decided to run its motion offense to solve the riddle of the Buckeye defense. Up to that point, Michigan's offense had been too predictable, as the Wolverines ran their set plays and tried to pound the ball inside with little effect. But in the second half, when the Wolverines switched to their motion offense, they more than doubled their point production from the first half. As a result of this success, Guevara plans to run more motion against the Hawkeyes. For the first few weeks of this sea- son, the Michigan women's tennis team has been talking about how it has been largely over- looked in the polls. Two weeks ago, the Wolver- VaRsITYT ines broke into the rank- Who: Michi< ings at No. 69. This week, No.6 Tenne they have perhaps their when: 6 p.m best opportunity of the Latest: TheV year to make a huge jump have droppe up the charts. ings agains "This is the best oppor- and are 31 tunity we're going to have against Sou for a while," No. 1 sin- ference opp gles player Kavitha Tipir- neni said. "We're definitely pumped." No. 8 Tennessee and No. 16 Ken- tucky come calling at the Varsity Tennis Center today and Saturday, looking to pad their records. But coming off an impressive 7-0 win against Illinois-Chicago last week- end, the Wolverines have different ideas. By Albert Kim Daily Sports Writer "We've seen that any team can beat any other team on a given day," assistant coach Danielle Lund said. "I definitely think we have a great shot at it." Tonight, INNIi CENTER gan (3-1) vs. ssee (4-3) M. Wolverines d all five meet- A Tennessee 7 all time theastern Con- mnents. the Wolverines will take on the Lady Vols, who are trying to recover from dropping two matches at the National Team Indoor Champi- onships. Michigan is currently looking to rebound from a tough loss to No. 13 Notre Dame. On Saturday, the Wolverines will close out their season-opening son why we can't beat them." The Wolverines are just starting to get comfortable with their lineup. No. 2 singles player Chrissie Nolan returned from a hamstring injury and has subsequently pulled off two straight wins. Michigan went to a new lineup against Illinois-Chicago last week- end and it worked well. "I think that our doubles combina- tions are an adjustment that we were very pleased with," Lund said. Said Tipirneni: "I think we've all been playing awesome. Everybody has gotten the job done, and we're all on the same page." Michigan will have its hands full against Tennessee, which it has never beaten in five matches. But Michigan fought hard against Notre Dame, and has played very well in all of its other matches. And never factor out the effect of having heroes of the past in atten- dance. "In general, the whole atmosphere will be a bit exciting with a lot of returning players," Lund said. a six-game homestand against Ken- tucky. Nostalgia will be in the air, as alumni tennis players will be on hand for a reunion weekend. Ken- tucky is coming off a whitewashing of Purdue and an upset win over Notre Dame. "They're a very talented team, they're going to be solid all the way through the lineup," Lund said. "But there's no rea- Young stymied b BOI LERMAKERS Continudfrom Page10A foul trouble (both fouls coming, foolishly, on inbound plays) and thus sat on the bench for the better part of the first half, and the better part of the game. Purdue's guards - Deane and sophomore Austin Parkinson - did their real damage on the defensive end, forcing Michigan to play a game it is not used to playing. "I think we created by clamping down on Young," Deane said. "We tried to get (the ball) in the hands of their least effective shooters. Michigan is more of a slashing team. We made it an emphasis to cut that out completely. "We tried to take (Robinson's) strengths away." y Purdue defense Robinson did end the game with team-high 13 points, but his teammates' shooting was abhorrent. Guards Leon Jones, Dommanic Ingerson and Gavin Groninger shot a combined 1-of-26 from the field. "They forced us to make outside shots," Groninger said. "Unfortunately, they just weren't going in." The guards weren't hitting their shots, and they couldn't find Young. Keady applauded his own defensive strategy, which worked for the Boilermakers on both ends, as they were able to turn 16 Michigan turnovers into 24 points. A somber Michigan coach Tommy Amaker - never one to make excuses - admitted that his team was "out- played, outhustled and outcoached in every facet of the game." 0 DANNY MOLOSHOK/Daily Michigan point guard Susana Jara and the Wolverines have had trouble recently playing good team defense on the road. Transfer RUbin will redshirt this spring By Brian Steere Daily Sports Writer . mi "." i " When the Michigan men's tennis team (5-0) faces Clemson and Alabama this weekend in its first road matches of the season, sopho- more Michael Rubin will remain at home in Ann Arbor. Rubin, who transferred to Michi- gan after fall semester, decided to redshirt this season and retain his three years of NCAA eligibility. He spent his freshman campaign play- ing No. 6 singles for Washington, which finished the year ranked No. 14 in the nation. "The predominant reason I left Washington was because I wanted to be closer to home," Rubin said. "Whether it be junior or high school tennis, my parents hardly missed any of my matches. But, out at Washington, it was almost impossi- ble for them to be there." Hailing from Canton, Ohio, Rubin won back-to-back state champi- onships in singles during his junior and senior years of high school. As a junior, he made his run for the title under the tutelage of Michigan coach Mark Mees, who was the director of tennis at the Cleveland Racket Club before he arrived in Ann Arbor. "I used to go up to Cleveland once a week for about five years and work with Mark," Rubin said. "The only reason we stopped was because he got the job here." Rubin's brother, Carey, is a fresh- man at Michigan and also chose to redshirt this season. Despite their absence from matches, the two remain intense practice partners. "We like to practice like animals," Carey said. "Pretty much going four hours a day and then we lift weights." That dedication is certainly admired by Mees. "Mike and Carey are two of the hardest working kids that I've ever been around,"Mees said. "What's nice is something like that rubs off on the rest of the team." After this season, the Wolverines will lose three of their six singles players, including No. 1 Henry Beam and No. 2 Ben Cox, leaving a large opening to be filled at the top. But (Michael) Rubin is content to let his tennis speak for itself. "I'm always gunning to play as high as I can," he said. "If I could play No. 1, I'd definitely jump at Contraceptive Injectionj medroxyprogesterone acetate injectable suspension irtk con~trol you-tkirnk a~outt just +)(~a year _o i DEPO-PROVERA*I Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To continue your contraceptive protection, you must return for your next inection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains inedroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstruaI cycle, it cannot become fertilized by sperm and result in pregnancy DEPO-PROVERA also causes changes in the lining of your uterus that make it less likely or pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see pHow often do I get my shot of DEPO-PROVERA Contraceptive Injection?"). To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first inection must be given ONLY during the first 5 days of a normal menstrual period; ONLY within the first S days after childbirth if not breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a Iong-term inecable contraceptive when administered at 3-month (13-week) intervals. DEPO-PROV RA Contraceptive Inection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVE RA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method, The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need in order to decide which contraceptive method is the right choice for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each method exactly as it should be used an the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use Lowest Method Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant) 0.2- O.2 Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 if you have had cancer of the breast "if you have had a stroke - if you have or have had blood clots (phlebitis) in your legs " if you have problems with your liver or liver disease - if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to tell your health-care provider if you have any of the following "a family history of breast cancer an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples " kidney disease irregular or scanty menstrual periods " high blood pressure migraine headaches. "asthma "epilepsy (convulsions or seizures) diabetes or a family history of diabetes "a history of depression if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Becau e DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to becomte pregnant, it is expected that about half of those who becomebpregnant will do so in about 10 months2after their lastinjection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so in about 15 months; and about 93% of those who become renant will do so in about 18 months after their last injection. The length of time you use EQ-PROVERA has no effect on how lon it takes you to become pregnant after you stop using it What are the risks of using DEPO-PROVERA Contraceptive Injection? I Irregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle. During the first year of using DEPO-PROVERA, you might have one or more of the following changes: irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA; and if this happens, you should see your health-care provider right away. With continued use of DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely. In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the re' Irmotlyorw f the liing of or u,,, terusc does no-t or and. ~ther-efr, the bleedilng 6 Other Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section. What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA: " sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot in the lung) * sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke) * severe pain or swelling in the calf (indicating a possible clot in the leg) " unusually heavy vaginal bleeding " severe pain or tenderness in the lower abdominal area Pesstent pain, pus, or bleeding at the injection site rat are the possible side effects of DEPO-PROVERA Contraceptive Injection? l.Weight Gain You may experience a weight gin while you are using DEPO-PROVERA. About two thirds of the women who used DEP0-PROVERA in clinical trials reported a weight gain of about 5 pounds during the -firstyear of use. You may continue to gain weight after the first year Women in one large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who continued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year: Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or ap roximately 2.75 pounds per year: 2. titer Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some worsen reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenonhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tendemess, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flashes, and joint pain. Other problems were reported by very few of the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer; or cervical cancer If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider. Should any precautions be followed during use of DEPO-PROVERA Contraceptive Injection? I.Missed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months (13 weeks), then you are probably not pregnant However; if you think that you may be pregnant, see your health-care provider 2.Laborotory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. A